193 related articles for article (PubMed ID: 33377228)
1. Targeting the mutant PIK3CA gene by DNA-alkylating pyrrole-imidazole polyamide in cervical cancer.
Krishnamurthy S; Yoda H; Hiraoka K; Inoue T; Lin J; Shinozaki Y; Watanabe T; Koshikawa N; Takatori A; Nagase H
Cancer Sci; 2021 Mar; 112(3):1141-1149. PubMed ID: 33377228
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
[TBL] [Abstract][Full Text] [Related]
3. Potent activity against K562 cells by polyamide-seco-CBI conjugates targeting histone H4 genes.
Minoshima M; Chou JC; Lefebvre S; Bando T; Shinohara K; Gottesfeld JM; Sugiyama H
Bioorg Med Chem; 2010 Jan; 18(1):168-74. PubMed ID: 19962902
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of DNA alkylation by conjugates between pyrrole-imidazole hairpin polyamides and chlorambucil or seco-CBI.
Minoshima M; Bando T; Shinohara K; Kashiwazaki G; Nishijima S; Sugiyama H
Bioorg Med Chem; 2010 Feb; 18(3):1236-43. PubMed ID: 20074970
[TBL] [Abstract][Full Text] [Related]
5. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
[TBL] [Abstract][Full Text] [Related]
6. A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function.
Ueno T; Fukuda N; Tsunemi A; Yao EH; Matsuda H; Tahira K; Matsumoto T; Matsumoto K; Matsumoto Y; Nagase H; Sugiyama H; Sawamura T
J Hypertens; 2009 Mar; 27(3):508-16. PubMed ID: 19330905
[TBL] [Abstract][Full Text] [Related]
7. Targeting specific gene by alkylating pyrrole-imidazole polyamides.
Minoshima M; Chou J; Lefebvre S; Bando T; Shinohara K; Gottesfeld JM; Sugiyama H
Nucleic Acids Symp Ser (Oxf); 2008; (52):363-4. PubMed ID: 18776404
[TBL] [Abstract][Full Text] [Related]
8. Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
Lin J; Hiraoka K; Watanabe T; Kuo T; Shinozaki Y; Takatori A; Koshikawa N; Chandran A; Otsuki J; Sugiyama H; Horton P; Nagase H
PLoS One; 2016; 11(10):e0165581. PubMed ID: 27798693
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological properties of pyrrole-imidazole polyamide conjugates.
Minoshima M; Sasaki S; Fujimoto J; Shinohara K; Bando T; Sugiyama H
Nucleic Acids Symp Ser (Oxf); 2007; (51):35-6. PubMed ID: 18029573
[TBL] [Abstract][Full Text] [Related]
10. Targeting of β-Catenin Reverses Radioresistance of Cervical Cancer with the
Jiang W; Wu Y; He T; Zhu H; Ke G; Xiang L; Yang H
Mol Cancer Ther; 2020 Feb; 19(2):337-347. PubMed ID: 31666350
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
Liu S; Tang Y; Yan M; Jiang W
Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of alkylating pyrrole-imidazole polyamide conjugates by a novel method for high-throughput sequencer.
Kashiwazaki G; Maeda R; Kawase T; Hashiya K; Bando T; Sugiyama H
Bioorg Med Chem; 2018 Jan; 26(1):1-7. PubMed ID: 29224995
[TBL] [Abstract][Full Text] [Related]
13. Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides.
Ota Y; Yoda H; Inoue T; Watanabe T; Shinozaki Y; Takatori A; Nagase H
PLoS One; 2021; 16(9):e0257718. PubMed ID: 34591871
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activities of alkylating pyrrole-imidazole polyamides with specific sequence recognition.
Shinohara K; Bando T; Sugiyama H
Anticancer Drugs; 2010 Mar; 21(3):228-42. PubMed ID: 20038830
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole-imidazole polyamide conjugate.
Hiraoka K; Inoue T; Taylor RD; Watanabe T; Koshikawa N; Yoda H; Shinohara K; Takatori A; Sugimoto H; Maru Y; Denda T; Fujiwara K; Balmain A; Ozaki T; Bando T; Sugiyama H; Nagase H
Nat Commun; 2015 Apr; 6():6706. PubMed ID: 25913614
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
Kim HJ; Lee SY; Kim CY; Kim YH; Ju W; Kim SC
Oncotarget; 2017 Jan; 8(4):6608-6622. PubMed ID: 28036259
[TBL] [Abstract][Full Text] [Related]
17. A novel pyrrole-imidazole polyamide targets Aurora kinase A and suppresses tumor growth in vivo.
Li M; Lu D; Cheng Y; Wu C; Zhang J; Shi W; Ding Z; Li Y; Cheng B; Lin X; Shao X; Li H; Fang L; Liu K; Su W
Biochem Biophys Res Commun; 2021 Sep; 571():167-173. PubMed ID: 34330060
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anti-cancer activity of pyrrole-imidazole polyamides through target-downregulation of c-kit gene expression.
Zhang M; Liang J; Jiang SK; Xu L; Wu YL; Awadasseid A; Zhao XY; Xiong XQ; Sugiyama H; Zhang W
Eur J Med Chem; 2020 Dec; 207():112704. PubMed ID: 32866755
[TBL] [Abstract][Full Text] [Related]
19. Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
Ippen FM; Grosch JK; Subramanian M; Kuter BM; Liederer BM; Plise EG; Mora JL; Nayyar N; Schmidt SP; Giobbie-Hurder A; Martinez-Lage M; Carter SL; Cahill DP; Wakimoto H; Brastianos PK
Neuro Oncol; 2019 Nov; 21(11):1401-1411. PubMed ID: 31173106
[TBL] [Abstract][Full Text] [Related]
20. Molecular design of sequence specific DNA alkylating agents.
Minoshima M; Bando T; Shinohara K; Sugiyama H
Nucleic Acids Symp Ser (Oxf); 2009; (53):69-70. PubMed ID: 19749264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
